Bavarian Nordic (OTCMKTS:BVNRY) Stock Crosses Above 50 Day Moving Average - Here's What Happened

Key Points

• Bavarian Nordic's share price surpassed its 50-day moving average of $11.39, hitting a high of $12.27 during trading, indicating strong market momentum.
• The company reported $251.14 million in revenue and $0.23 earnings per share for the most recent quarter, highlighting its financial stability.
• Bavarian Nordic has a market capitalization of $2.90 billion and is involved in the development of life-saving vaccines, including those for smallpox and rabies.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report)'s share price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $11.39 and traded as high as $12.27. Bavarian Nordic shares last traded at $12.27, with a volume of 592 shares changing hands.

Bavarian Nordic Stock Performance

The stock has a market capitalization of $2.90 billion, a P/E ratio of 14.02 and a beta of 1.30. The company's fifty day simple moving average is $11.59 and its two-hundred day simple moving average is $9.36.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last released its quarterly earnings results on Friday, August 22nd. The company reported $0.23 earnings per share for the quarter. The firm had revenue of $251.14 million for the quarter. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%. On average, research analysts predict that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.

About Bavarian Nordic

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.